drugset / Trial / NCT01101061
A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women
RandomizedSequentialDouble-blindTreatment
Summary
The main purpose of this study is to assess the safety, tolerability and potential immune response to romosozumab following single subcutaneous (SC; injection under the skin) dose administration in healthy postmenopausal Japanese and non-Japanese women.
Timeline
- Start
- 2010-05-03
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Romosozumab | Monoclonal antibody | 1 mg/kg | Subcutaneous |
| Subject | Romosozumab | Monoclonal antibody | 3 mg/kg | Subcutaneous |
| Subject | Romosozumab | Monoclonal antibody | 5 mg/kg | Subcutaneous |
Indications
No indication recorded.